← Open Payments lookup

PAUL KLAASSEN: Open Payments

NPI 1053313361 · ARKANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$233 in 13 payments from 8 companies in 2025. Trend: 2023 $110 · 2024 $149 · 2025 $233

Food & beverage: $233
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$62
Novo Nordisk Inc2$44
Boehringer Ingelheim Pharmaceuticals, Inc.2$36
Vanda Pharmaceuticals Inc.1$25
GlaxoSmithKline, LLC.1$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15
Amgen Inc.1$14
PFIZER INC.1$14

Products named: CAPLYTA, Wegovy, JARDIANCE, FANAPT, TRELEGY ELLIPTA, XIFAXAN, EVENITY, PREVNAR 20.

Industry payments across KS — which companies pay providers there.